Update on Management of Coats’ Disease

Author(s):  
Janelle Fassbender Adeniran ◽  
Oluwasayo Akinyosoye ◽  
Aparna Ramasubramanian
Keyword(s):  
2010 ◽  
Vol 88 (2) ◽  
pp. e48-e49 ◽  
Author(s):  
Peter Cackett ◽  
Doric Wong ◽  
Chui Ming Gemmy Cheung

1927 ◽  
Vol 20 (9) ◽  
pp. 1435-1436
Author(s):  
Rupert Scott
Keyword(s):  

1980 ◽  
Vol 98 (11) ◽  
pp. 2004-2006 ◽  
Author(s):  
G. F. Judisch ◽  
D. J. Apple

1999 ◽  
Vol 19 (2) ◽  
pp. 112
Author(s):  
L Eisenberg ◽  
M Castillo ◽  
L Kwock ◽  
S K Mukherji ◽  
D K Wallace

1984 ◽  
Vol 21 (5) ◽  
pp. 163-168
Author(s):  
Meimei Chang ◽  
Ian W McLean ◽  
John C Merritt
Keyword(s):  

2015 ◽  
Vol 2 (3) ◽  
pp. 140-143 ◽  
Author(s):  
Naina Gupta ◽  
William Terrell ◽  
Lynn Schoenfield ◽  
Claudia Kirsch ◽  
Colleen M. Cebulla

2016 ◽  
Vol 10 (1) ◽  
pp. 22-26 ◽  
Author(s):  
Salvatore Perrone ◽  
Alberto Rossetti ◽  
Patrick Sportiello ◽  
Pierfrancesco Mirabelli ◽  
Pierangela Cimatti ◽  
...  

Purpose: To report on the outcome of conventional therapy in patients with Coats’ disease. Methods: Retrospective analysis of the charts of thirteen patients with Coats’ disease. Results: Mean age of 9 male (70%) and 4 female (30%) patients was 17.7 (range, 5-33) years; one female had bilateral disease. Eleven eyes with retinal telangiectasia and exudation were treated with argon laser photocoagulation alone or photocoagulation associated with cryotherapy; the mean follow up was 32.5 (range,17-41) years. In four eyes without foveal involvement (stage 2a) the mean presenting visual acuity (VA) remained at 0.8 or improved, whereas poor VA in seven stage 2b eyes deteriorated minimally over time. In one and two of the three eyes with total retinal detachment, phthisis or neovascular glaucoma ensued. Conclusion: About three decades after conventional treatment of Coats’ disease stage 2a, treated eyes maintained good VA, and stage 2b eyes did not progress to advanced stages.


Sign in / Sign up

Export Citation Format

Share Document